|
|
|
Insider
Information: |
Beshar Luke M |
Relationship: |
Director |
City: |
East Rutherford |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
198,000 |
|
Indirect Shares
|
1,081 |
|
|
Direct
Value |
$556,380 |
|
|
Indirect Value
|
$64,795 |
|
|
Total
Shares |
199,081 |
|
|
Total
Value |
$621,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-4.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cambrex Corp |
CBM |
Executive Vice President |
2007-10-10 |
0 |
2005-12-31 |
1,081 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
EVP & CFO |
2015-02-21 |
0 |
2011-01-31 |
0 |
Premium* |
|
Regenxbio Inc. |
RGNX |
|
2018-11-29 |
0 |
2018-11-19 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2022-06-30 |
198,000 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RGNX |
Regenxbio Inc. |
|
|
2018-11-19 |
4 |
OE |
$12.74 |
$288,138 |
D/D |
12,116 |
12,116 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-10-31 |
4 |
AS |
$29.00 |
$290,000 |
D/D |
(10,000) |
72,780 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2018-11-27 |
4 |
OE |
$3.76 |
$346,908 |
D/D |
18,786 |
18,786 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-12-17 |
4 |
OE |
$3.34 |
$373,670 |
D/D |
52,258 |
125,038 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-12 |
4 |
OE |
$8.21 |
$496,735 |
D/D |
60,311 |
119,491 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP &CFO |
|
2011-01-31 |
4 |
AS |
$10.00 |
$500,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-17 |
4 |
OE |
$19.43 |
$572,571 |
D/D |
29,256 |
52,165 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-04-10 |
4 |
AS |
$12.00 |
$600,220 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-05-09 |
4 |
AS |
$14.18 |
$640,001 |
D/D |
(45,150) |
59,180 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-17 |
4 |
S |
$22.40 |
$655,764 |
D/D |
(29,256) |
22,909 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-16 |
4 |
OE |
$20.72 |
$656,207 |
D/D |
30,700 |
53,609 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-16 |
4 |
S |
$22.60 |
$695,207 |
D/D |
(30,700) |
22,909 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-20 |
4 |
OE |
$18.68 |
$700,492 |
D/D |
36,544 |
59,453 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2018-11-19 |
4 |
AS |
$60.26 |
$733,602 |
D/D |
(12,116) |
0 |
0 |
- |
|
CBM |
Cambrex Corp |
Executive VP & CFO |
|
2006-11-20 |
4 |
S |
$22.25 |
$800,838 |
D/D |
(35,844) |
23,609 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-10-27 |
4 |
AS |
$26.75 |
$819,606 |
D/D |
(30,635) |
82,780 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2018-11-29 |
4 |
AS |
$65.00 |
$830,960 |
D/D |
(12,784) |
0 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-01-08 |
4 |
AS |
$35.01 |
$1,105,896 |
D/D |
(31,588) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-26 |
4 |
AS |
$30.02 |
$1,136,977 |
D/D |
(37,874) |
59,180 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2018-11-27 |
4 |
AS |
$65.03 |
$1,221,654 |
D/D |
(18,786) |
0 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2018-11-20 |
4 |
AS |
$60.38 |
$1,278,607 |
D/D |
(21,176) |
0 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-16 |
4 |
AS |
$27.89 |
$1,394,576 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-11-17 |
4 |
AS |
$30.01 |
$1,423,640 |
D/D |
(47,442) |
72,780 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-12 |
4 |
AS |
$24.02 |
$1,448,387 |
D/D |
(60,311) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-20 |
4 |
AS |
$30.05 |
$1,512,875 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
77 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|